Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01066143 · ClinicalTrials.gov registry record · NA
Generalized Anxiety and Seroquel
A NA study, sponsored by Mclean Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01066143: Clinical Trial NA study, sponsored by Mclean Hospital.
NCT01066143 is a NA study that was terminated before completion, run by Mclean Hospital. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01066143, a NA study, was terminated before completion, sponsored by Mclean Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The 12 week clinical trial of Seroquel in Generalized Anxiety Disorder (GAD) patients will be combined with fMRI experiments.
Primary Outcome
Changes in anxiety symptomatolgy
Interventions
- DRUG Seroquel XR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-02 |
| Phase | NA |
Why NCT01066143 stopped before completion
NCT01066143 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Seroquel XR is the first listed.
NCT01066143 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01066143 about?
NCT01066143 is a clinical study titled "Generalized Anxiety and Seroquel". The 12 week clinical trial of Seroquel in Generalized Anxiety Disorder (GAD) patients will be combined with fMRI experiments.
What is the current status of trial NCT01066143?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2010-02. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01066143?
The interventions under investigation include: Seroquel XR (DRUG).
Who is sponsoring clinical trial NCT01066143?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01066143's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia